Sanofi Price to Sales Ratio 2006-2018 | SNY

Historical PS ratio values for Sanofi (SNY) over the last 10 years. The current P/S ratio for Sanofi as of March 21, 2019 is .
Sanofi P/S Ratio Historical Data
Date Stock Price TTM Sales per Share Price to Sales Ratio
2019-03-21 45.43 3.61
2018-06-30 40.01 $12.57 3.18
2018-03-31 38.26 $16.48 2.32
2017-12-31 41.05 $16.23 2.53
2017-09-30 47.53 $15.88 2.99
2017-06-30 45.73 $15.51 2.95
2017-03-31 41.78 $15.25 2.74
2016-12-31 37.34 $14.89 2.51
2016-09-30 35.26 $15.19 2.32
2016-06-30 38.64 $15.17 2.55
2016-03-31 35.56 $15.77 2.26
2015-09-30 42.04 $16.30 2.58
2015-06-30 43.86 $16.63 2.64
2014-06-30 45.60 $16.88 2.70
2013-06-30 42.64 $17.03 2.50
2012-06-30 30.22 $17.62 1.71
2012-03-31 29.61 $17.83 1.66
2011-12-31 27.93 $17.94 1.56
2011-09-30 25.07 $17.40 1.44
2011-06-30 30.70 $17.02 1.80
2011-03-31 26.02 $16.45 1.58
2010-12-31 23.81 $15.82 1.51
2010-09-30 24.56 $15.82 1.55
2010-06-30 22.20 $15.87 1.40
2010-03-31 26.62 $15.83 1.68
2009-12-31 27.98 $15.62 1.79
2009-09-30 26.33 $15.85 1.66
2009-06-30 21.01 $15.54 1.35
2009-03-31 18.86 $15.46 1.22
2008-12-31 21.72 $19.90 1.09
2008-09-30 22.20 $19.69 1.13
2008-06-30 22.44 $19.56 1.15
2008-03-31 24.28 $19.06 1.27
2007-12-31 29.45 $14.69 2.00
2007-09-30 27.44 $14.33 1.91
2007-06-30 26.05 $13.86 1.88
2007-03-31 27.46 $13.71 2.00
2006-12-31 29.14 $13.24 2.20
Sector Industry Market Cap Revenue
Medical Large Cap Pharmaceutical $113.892B $40.701B
Sanofi-Aventis is a global pharmaceutical company that contributes to enhance life by providing medicines, vaccines, and integrated healthcare solutions adapted to local needs and means primarily in Europe and the United States. The company is engaged in the research, development, manufacture and marketing of healthcare products. Its strategy is built around three priorities to reach its goals and ensure sustainable growth. The priorities are: increasing innovation in Research and Development, adapting Group structures to future challenges and seizing external growth opportunities. Sanofi-Aventis specializes in six therapeutic areas: thrombosis, cardiovascular, metabolic disorders, oncology, central nervous system (CNS) and internal medicine. The Company offers vaccines in five areas: pediatric combination vaccines, influenza vaccines, adult and adolescent booster vaccines, meningitis vaccines, and travel and endemic vaccines. Sanofi-Aventis is headquartered in Paris, France.
Stock Name Country Market Cap PE Ratio
Johnson & Johnson (JNJ) United States $368.336B 16.78
Pfizer (PFE) United States $251.032B 14.06
Merck (MRK) United States $221.303B 18.91
Novartis AG (NVS) Switzerland $215.939B 18.36
Eli Lilly (LLY) United States $132.699B 23.05
Novo Nordisk (NVO) Denmark $128.603B 20.80
AbbVie (ABBV) United States $118.641B 10.17
AstraZeneca (AZN) United Kingdom $108.965B 12.43
GlaxoSmithKline (GSK) United Kingdom $101.233B 13.29
Bristol-Myers Squibb (BMY) United States $80.311B 12.36